Liposomal cytarabine and daunorubicin (CPX-351/Vyxeos)-associated distinct purpuric subtype of toxic erythema of chemotherapy: A retrospective review of 54 patients

J Am Acad Dermatol. 2022 Jan;86(1):232-234. doi: 10.1016/j.jaad.2021.01.096. Epub 2021 Feb 2.

Abstract

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Cytarabine* / adverse effects
  • Daunorubicin / adverse effects
  • Erythema / chemically induced
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Retrospective Studies

Substances

  • CPX-351
  • Cytarabine
  • Daunorubicin